NOVOCURE LTD (NVCR) Stock Income Statement
NASDAQ:NVCR - Nasdaq - JE00BYSS4X48 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 621.71M | 605.22M | 509.34M | 537.80M | 535.00M | |||
| Cost Of Goods | 142.01M | 137.13M | 128.28M | 114.90M | 114.90M | |||
| Gross Profit | 479.70M | 468.09M | 381.06M | 423.00M | 420.20M | |||
| Operating Expenses | 646.57M | 636.58M | 613.93M | 512.50M | 464.50M | |||
| Research and Development | 211.82M | 209.37M | 223.06M | 206.10M | 201.30M | |||
| Selling, General, and Administrative Expenses | 434.74M | 427.21M | 390.87M | 306.40M | 263.20M | |||
| Operating Income | -166.87M | -168.49M | -232.87M | -89.50M | -44.30M | |||
| Interest Income/Expense | 38.35M | 11.66M | 15.46M | 3.50M | -7.30M | |||
| Other Income/Expense | N/A | 27.67M | 25.66M | 4.10M | -500.00K | |||
| Non Recurring Items | N/A | -2.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -129.81M | -131.16M | -191.74M | -81.80M | -52.10M | |||
| Income Tax | 34.37M | 37.47M | 15.30M | 10.70M | 6.30M | |||
| Net Income | -164.19M | -168.63M | -207.04M | -92.50M | -58.40M | |||
| EBITDA | -155.12M | -157.26M | -221.90M | -78.88M | -34.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.51 | -1.56 | -1.95 | -0.88 | -0.56 | |||
| Non GAAP EPS | -1.51 | -1.56 | -1.95 | -0.88 | -0.56 | |||
| Statistics | ||||||||
| Gross Profit Margin | 77.16% | 77.34% | 74.81% | 78.65% | 78.54% | |||
| Profit Margin | -26.41% | -27.86% | -40.65% | -17.20% | -10.92% | |||
| Operating Profit Margin | -26.84% | -27.84% | -45.72% | -16.64% | -8.28% | |||
All data in USD